Probiotics and necrotizing enterocolitis

Seminars in Pediatric Surgery

Volumn 27, Issue 1, 2018, Pages 39-46

  Patel, Ravi Mangal ^a   Underwood, Mark A ^b  

^a CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bacteria; Gut; Meta analysis; Microbiome; Neonate; Preterm

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; DRUG SAFETY; DYSBIOSIS; EPIDEMIOLOGICAL DATA; HUMAN; LONG TERM CARE; MICROBIOME; NECROTIZING ENTEROCOLITIS; NEWBORN MORTALITY; NEWBORN SEPSIS; NONHUMAN; PATHOPHYSIOLOGY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; TIME TO TREATMENT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; INTESTINE FLORA; MICROBIOLOGY; NEWBORN; PREMATURITY;

ENTEROCOLITIS, NECROTIZING; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PROBIOTICS; TREATMENT OUTCOME;

EID: 85034862234     PISSN: 10558586     EISSN: 15329453     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2017.11.008     Document Type: Article

References (85)

1. Frost, B.L., Modi, B.P., Jaksic, T., Caplan, M.S., New medical and surgical insights into neonatal necrotizing enterocolitis: a review. JAMA Pediatr 171:1 (2017), 83–88.
2. Nino, D.F., Sodhi, C.P., Hackam, D.J., Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol Hepatol 13:10 (2016), 590–600.
3. Battersby, C., Longford, N., Mandalia, S., Costeloe, K., Modi, N., U. K. Neonatal Collaborative Necrotising Enterocolitis study group. Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012–13: a whole-population surveillance study. Lancet Gastroenterol Hepatol 2:1 (2017), 43–51.
4. Pammi, M., Cope, J., Tarr, P.I., Warner, B.B., Morrow, A.L., Mai, V., et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome, 5(1), 2017, 31.
5. Warner, B.B., Deych, E., Zhou, Y., Hall-Moore, C., Weinstock, G.M., Sodergren, E., et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet 387:10031 (2016), 1928–1936.
6. Patel, R.M., Kandefer, S., Walsh, M.C., Bell, E.F., Carlo, W.A., Laptook, A.R., et al. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 372:4 (2015), 331–340.
7. Samuels, N., van de Graaf, R.A., de Jonge, R.C.J., Reiss, I.K.M., Vermeulen, M.J., Risk factors for necrotizing enterocolitis in neonates: a systematic review of prognostic studies. BMC Pediatr, 17(1), 2017, 105.
8. Quigley, M., McGuire, W., Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev(4), 2014 CD002971.
9. O'Connor, D.L., Gibbins, S., Kiss, A., Bando, N., Brennan-Donnan, J., Ng, E., et al. Effect of supplemental donor human milk compared with preterm formula on neurodevelopment of very low-birth-weight infants at 18 months: a randomized clinical trial. J Am Med Assoc 316:18 (2016), 1897–1905.
10. Guillet, R., Stoll, B.J., Cotten, C.M., Gantz, M., McDonald, S., Poole, W.K., et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 117:2 (2006), e137–e142.
11. Cotten, C.M., Taylor, S., Stoll, B., Goldberg, R.N., Hansen, N.I., Sanchez, P.J., et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123:1 (2009), 58–66.
12. Kuppala, V.S., Meinzen-Derr, J., Morrow, A.L., Schibler, K.R., Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 159:5 (2011), 720–725.
13. Carrion, V., Egan, E.A., Prevention of neonatal necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 11:3 (1990), 317–323.
14. Bury, R.G., Tudehope, D., Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev(1), 2001, CD000405.
15. Sodhi, C., Richardson, W., Gribar, S., Hackam, D.J., The development of animal models for the study of necrotizing enterocolitis. Dis Model Mech 1:2–3 (2008), 94–98.
16. Underwood, M.A., German, J.B., Lebrilla, C.B., Mills, D.A., Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatr Res 77:1–2 (2015), 229–235.
17. Torrazza, R.M., Ukhanova, M., Wang, X., Sharma, R., Hudak, M.L., Neu, J., et al. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLoS One, 8(12), 2013, e83304.
18. Penders, J., Thijs, C., Vink, C., Stelma, F.F., Snijders, B., Kummeling, I., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:2 (2006), 511–521.
19. Denning, T.W., Bhatia, A.M., Kane, A.F., Patel, R.M., Denning, P.W., Pathogenesis of NEC: role of the innate and adaptive immune response. Semin Perinatol 41:1 (2017), 15–28.
20. Jilling, T., Simon, D., Lu, J., Meng, F.J., Li, D., Schy, R., et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 177:5 (2006), 3273–3282.
21. Leaphart, C.L., Cavallo, J., Gribar, S.C., Cetin, S., Li, J., Branca, M.F., et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 179:7 (2007), 4808–4820.
22. Gomez-Llorente, C., Munoz, S., Gil, A., Role of toll-like receptors in the development of immunotolerance mediated by probiotics. Proc Nutr Soc 69:3 (2010), 381–389.
23. Underwood, M.A., Impact of probiotics on necrotizing enterocolitis. Semin Perinatol 41:1 (2017), 41–51.
24. Hooper, L.V., Wong, M.H., Thelin, A., Hansson, L., Falk, P.G., Gordon, J.I., Molecular analysis of commensal host-microbial relationships in the intestine. Science 291:5505 (2001), 881–884.
25. Lin, P.W., Myers, L.E., Ray, L., Song, S.C., Nasr, T.R., Berardinelli, A.J., et al. Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med 47:8 (2009), 1205–1211.
26. Neish, A.S., Gewirtz, A.T., Zeng, H., Young, A.N., Hobert, M.E., Karmali, V., et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289:5484 (2000), 1560–1563.
27. Wickramasinghe, S., Pacheco, A.R., Lemay, D.G., Mills, D.A., Bifidobacteria grown on human milk oligosaccharides downregulate the expression of inflammation-related genes in Caco-2 cells. BMC Microbiol, 15, 2015, 172.
28. Underwood, M.A., Arriola, J., Gerber, C.W., Kaveti, A., Kalanetra, K.M., Kananurak, A., et al. Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota. Pediatr Res 76:4 (2014), 326–333.
29. Kumar, A., Wu, H., Collier-Hyams, L.S., Kwon, Y.M., Hanson, J.M., Neish, A.S., The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation. J Immunol 182:1 (2009), 538–546.
30. Rivera-Chavez, F., Lopez, C.A., Baumler, A.J., Oxygen as a driver of gut dysbiosis. Free Radic Biol Med 105 (2017), 93–101.
31. Bron, P.A., Kleerebezem, M., Brummer, R.J., Cani, P.D., Mercenier, A., MacDonald, T.T., et al. Can probiotics modulate human disease by impacting intestinal barrier function?. Br J Nutr 117:1 (2017), 93–107.
32. Patel, R.M., Myers, L.S., Kurundkar, A.R., Maheshwari, A., Nusrat, A., Lin, P.W., Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol 180:2 (2012), 626–635.
33. Martinez, F.A., Balciunas, E.M., Converti, A., Cotter, P.D., de Souza Oliveira, R.P., Bacteriocin production by Bifidobacterium spp. A review. Biotechnol Adv 31:4 (2013), 482–488.
34. Walker, W.A., Mechanisms of action of probiotics. Clin Infect Dis 46:suppl 2 (2008), S87–S91 discussion S144-51.
35. Sawh, S.C., Deshpande, S., Jansen, S., Reynaert, C.J., Jones, P.M., Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis. PeerJ, 4, 2016, e2429.
36. Patel, R.M., Denning, P.W., Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?. Clin Perinatol 40:1 (2013), 11–25.
37. Lin, H.C., Hsu, C.H., Chen, H.L., Chung, M.Y., Hsu, J.F., Lien, R.I., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122:4 (2008), 693–700.
38. Costeloe, K., Hardy, P., Juszczak, E., Wilks, M., Millar, M.R., Probiotics in Preterm Infants Study Collaborative Group Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387:10019 (2016), 649–660.
39. Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., et al. The “Golden Age” of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants. Neonatology 112:1 (2017), 9–23.
40. Rao, S.C., Athalye-Jape, G.K., Deshpande, G.C., Simmer, K.N., Patole, S.K., Probiotic supplementation and late-onset sepsis in preterm infants: a meta-analysis. Pediatrics, 137(3), 2016, e20153684.
41. Hartel, C., Pagel, J., Rupp, J., Bendiks, M., Guthmann, F., Rieger-Fackeldey, E., et al. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants. J Pediatr 165:2 (2014), 285–289 e1.
42. Viswanathan, S., Lau, C., Akbari, H., Hoyen, C., Walsh, M.C., Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States. J Perinatol 36:12 (2016), 1106–1111.
43. Manzoni, P., Mostert, M., Leonessa, M.L., Priolo, C., Farina, D., Monetti, C., et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 42:12 (2006), 1735–1742.
44. Manzoni, P., Rinaldi, M., Cattani, S., Pugni, L., Romeo, M.G., Messner, H., et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. J Am Med Assoc 302:13 (2009), 1421–1428.
45. Bonsante, F., Iacobelli, S., Gouyon, J.B., Routine probiotic use in very preterm infants: retrospective comparison of two cohorts. Am J Perinatol 30:1 (2013), 41–46.
46. Hunter, C., Dimaguila, M.A., Gal, P., Wimmer, J.E. Jr, Ransom, J.L., Carlos, R.Q., et al. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight <1000 grams: a sequential analysis. BMC Pediatr, 12, 2012, 142.
47. Athalye-Jape, G., Rao, S., Patole, S., Lactobacillus reuteri DSM 17938 as a probiotic for preterm neonates: a strain-specific systematic review. JPEN J Parenter Enteral Nutr 40:6 (2016), 783–794.
48. Oncel, M.Y., Sari, F.N., Arayici, S., Guzoglu, N., Erdeve, O., Uras, N., et al. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 99:2 (2014), F110–F115.
49. Thomas, J.P., Raine, T., Reddy, S., Belteki, G., Probiotics for the prevention of necrotising enterocolitis in very low-birth-weight infants: a meta-analysis and systematic review. Acta Paediatr 106:11 (2017), 1729–1741.
50. Kolacek, S., Hojsak, I., Berni Canani, R., Guarino, A., Indrio, F., Orel, R., et al. Commercial probiotic products: a call for improved quality control. A position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 65:1 (2017), 117–124.
51. Lewis, Z.T., Shani, G., Masarweh, C.F., Popovic, M., Frese, S.A., Sela, D.A., et al. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res 79:3 (2016), 445–452.
52. Sanders, M.E., Shane, A.L., Merenstein, D.J., Advancing probiotic research in humans in the United States: challenges and strategies. Gut Microbes 7:2 (2016), 97–100.
53. Dani, C., Coviello, C.C., Corsini, I.I., Arena, F., Antonelli, A., Rossolini, G.M., Lactobacillus Sepsis and probiotic therapy in newborns: two new cases and literature review. AJP Rep 6:1 (2016), e25–e29.
54. Ipson, M.A., Blanco, C.L., Saccharomyces cerevisiae sepsis in a 35-week-old premature infant. A case report. J Perinatol 21:7 (2001), 459–460.
55. Chioukh, F.Z., Ben Hmida, H., Ben Ameur, K., Toumi, A., Monastiri, K., Saccharomyces cerevisiae fungemia in a premature neonate treated receiving probiotics. Med Mal Infect 43:8 (2013), 359–360.
56. Vallabhaneni, S., Walker, T.A., Lockhart, S.R., Ng, D., Chiller, T., Melchreit, R., et al. Notes from the field: fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement—Connecticut, 2014. MMWR Morb Mortal Wkly Rep 64:6 (2015), 155–156.
57. U.S. Food and Drug Administration. FDA Investigates Presence of Mucormycosis-causing Mold in Infant and Children's Probiotic Supplement, 2016 Available from https://www.fda.gov/Food/RecallsOutbreaksEmergencies/Outbreaks/ucm423830.htm.
58. Akar, M., Eras, Z., Oncel, M.Y., Arayici, S., Guzoglu, N., Canpolat, F.E., et al. Impact of oral probiotics on neurodevelopmental outcomes in preterm infants. J Matern Fetal Neonatal Med 30:4 (2017), 411–415.
59. Zuccotti, G., Meneghin, F., Aceti, A., Barone, G., Callegari, M.L., Di Mauro, A., et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy 70:11 (2015), 1356–1371.
60. Underwood, M.A., Kalanetra, K.M., Bokulich, N.A., Lewis, Z.T., Mirmiran, M., Tancredi, D.J., et al. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr 163:6 (2013), 1585–1591 e9.
61. Guthmann, F., Arlettaz Mieth, R.P., Bucher, H.U., Buhrer, C., Short courses of dual-strain probiotics appear to be effective in reducing necrotising enterocolitis. Acta Paediatr 105:3 (2016), 255–259.
62. Chang, H.Y., Chen, J.H., Chang, J.H., Lin, H.C., Lin, C.Y., Peng, C.C., Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: an updated meta-analysis. PLoS One, 12(2), 2017, e0171579.
63. Bin-Nun, A., Bromiker, R., Wilschanski, M., Kaplan, M., Rudensky, B., Caplan, M., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 147:2 (2005), 192–196.
64. Lin, H.C., Su, B.H., Chen, A.C., Lin, T.W., Tsai, C.H., Yeh, T.F., et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115:1 (2005), 1–4.
65. Samanta, M., Sarkar, M., Ghosh, P., Ghosh, J., Sinha, M., Chatterjee, S., Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 55:2 (2009), 128–131.
66. Jacobs, S.E., Tobin, J.M., Opie, G.F., Donath, S., Tabrizi, S.N., Pirotta, M., et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 132:6 (2013), 1055–1062.
67. Dilli, D., Aydin, B., Fettah, N.D., Ozyazici, E., Beken, S., Zenciroglu, A., et al. The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. J Pediatr 166:3 (2015), 545–551 e1.
68. Janvier, A., Malo, J., Barrington, K.J., Cohort study of probiotics in a North American neonatal intensive care unit. J Pediatr 164:5 (2014), 980–985.
69. Patole, S.K., Rao, S.C., Keil, A.D., Nathan, E.A., Doherty, D.A., Simmer, K.N., Benefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates—a retrospective cohort study. PLoS One, 11(3), 2016, e0150775.
70. Morgan, J., Young, L., McGuire, W., Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev(10), 2015, CD001241.
71. Abrams, S.A., Schanler, R.J., Lee, M.L., Rechtman, D.J., Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products. Breastfeed Med 9:6 (2014), 281–285.
72. Kantorowska, A., Wei, J.C., Cohen, R.S., Lawrence, R.A., Gould, J.B., Lee, H.C., Impact of Donor milk availability on breast milk use and necrotizing enterocolitis rates. Pediatrics, 137(3), 2016, e20153123.
73. Herrmann, K., Carroll, K., An exclusively human milk diet reduces necrotizing enterocolitis. Breastfeed Med 9:4 (2014), 184–190.
74. Hair, A.B., Peluso, A.M., Hawthorne, K.M., Perez, J., Smith, D.P., Khan, J.Y., et al. Beyond Necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk-based diet. Breastfeed Med 11:2 (2016), 70–74.
75. Assad, M., Elliott, M.J., Abraham, J.H., Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol 36:3 (2016), 216–220.
76. Dani, C., Biadaioli, R., Bertini, G., Martelli, E., Rubaltelli, F.F., Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82:2 (2002), 103–108.
77. Luoto, R., Matomaki, J., Isolauri, E., Lehtonen, L., Incidence of necrotizing enterocolitis in very-low-birth-weight infants related to the use of Lactobacillus GG. Acta Paediatr 99:8 (2010), 1135–1138.
78. Rojas, M.A., Lozano, J.M., Rojas, M.X., Rodriguez, V.A., Rondon, M.A., Bastidas, J.A., et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 130:5 (2012), e1113–e1120.
79. Repa, A., Thanhaeuser, M., Endress, D., Weber, M., Kreissl, A., Binder, C., et al. Probiotics (Lactobacillus acidophilus and Bifidobacterium infantis) prevent NEC in VLBW infants fed breast milk but not formula [corrected]. Pediatr Res 77:2 (2015), 381–388.
80. Li, D., Rosito, G., Slagle, T., Probiotics for the prevention of necrotizing enterocolitis in neonates: an 8-year retrospective cohort study. J Clin Pharm Ther 38:6 (2013), 445–449.
81. Al-Hosni, M., Duenas, M., Hawk, M., Stewart, L.A., Borghese, R.A., Cahoon, M., et al. Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol 32:4 (2012), 253–259.
82. Dang, S., Shook, L., Garlitz, K., Hanna, M., Desai, N., Nutritional outcomes with implementation of probiotics in preterm infants. J Perinatol 35:6 (2015), 447–450.
83. Kitajima, H., Sumida, Y., Tanaka, R., Yuki, N., Takayama, H., Fujimura, M., Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 76:2 (1997), F101–F107.
84. Patole, S., Keil, A.D., Chang, A., Nathan, E., Doherty, D., Simmer, K., et al. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates—a randomised double blind placebo controlled trial. PLoS One, 9(3), 2014, e89511.
85. Fujii, T., Ohtsuka, Y., Lee, T., Kudo, T., Shoji, H., Sato, H., et al. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. J Pediatr Gastroenterol Nutr 43:1 (2006), 83–88.